MrIC, a novel α-conotoxin agonist in the presence of PNU at endogenous α7 nicotinic acetylcholine receptors.

Biochemistry

Institute for Molecular Bioscience, The University of Queensland , Brisbane, QLD 4072, Australia , and Discipline of Pharmacology, The University of Sydney, Sydney, NSW 2006, Australia.

Published: January 2014

α-Conotoxins are competitive antagonists of nicotinic acetylcholine receptors (nAChRs). Their high selectivity and affinity for the various subtypes of nAChRs have led to significant advances in our understanding of the structure and function of these key ion channels. Here we report the discovery of a novel 4/7 α-conotoxin, MrIC from the venom duct of Conus marmoreus, which acts as an agonist at the endogenous human α7 nAChR in SH-SY5Y cells pretreated with PNU120596 (PNU). This unique agonist activity of MrIC at α7 nAChRs may guide the development of novel α7 nAChR modulators.

Download full-text PDF

Source
http://dx.doi.org/10.1021/bi400882sDOI Listing

Publication Analysis

Top Keywords

nicotinic acetylcholine
8
acetylcholine receptors
8
α7 nachr
8
mric novel
4
novel α-conotoxin
4
α-conotoxin agonist
4
agonist presence
4
presence pnu
4
pnu endogenous
4
α7
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!